| MDL | - |
|---|---|
| Molecular Weight | 446.71 |
| Molecular Formula | C28H50N2O2 |
| SMILES | [H][C@]1([C@](CCCCCC[C@@](CCN2CCC3)([H])O[C@@]2([H])[C@]3([H])CCCCCC4)([H])CCC5)N5CC[C@]4([H])O1 |
Xestospongin C ((-)-Xestospongin C) is a selective, reversible inositol 1,4,5-trisphosphate receptor (IP3R) inhibitor. Xestospongin C acts as an inhibitor of the sarcoplasmic/endoplasmic reticulum Ca 2+ ATPase (SERCA) pump of internal stores. Xestospongin C blocks IP3-induced Ca 2+ release from cerebellar microsomes with an IC 50 of 358 nM. Xestospongin C is a valuable tool for investigating the structure and function of IP3Rs and Ca 2+ signaling in neuronal and nonneuronal cells [1] [2] [3] .
|
IP3R |
Xestospongin C (XeC; 10 μM; 1 h before Aβ) pretreatment before Aβ
1-42
(20 μM; 24 hours) application displays a significant decrease in the early apoptotic rate (9.87%) compared to the Aβ alone treated group (18.38%)
[1]
.
Xestospongin C (10 μM; 1 h before Aβ) and Aβ
1-42
(20 μM; 100 s) has significant main effects on the peak value and average values of Ca
2+
changes, as well as a significant interaction in primary cultured hippocampal neurons
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Xestospongin C (3 μM; intracerebroventrical injection by a pump for four weeks) ameliorates the disinhibition-like behavior and long term spatial memory deficits of 8-month-old male APP/PS1 mice of Alzheimer's disease [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Viscous liquid
a marine sponge, Xestospongia sp.
Room temperature in continental US; may vary elsewhere.
| Pure form | -20°C | 3 years |
|---|---|---|
| In solvent | -80°C | 6 months |
| -20°C | 1 month |